These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12952838)

  • 1. Myocardial collagen turnover in hypertrophic cardiomyopathy.
    Lombardi R; Betocchi S; Losi MA; Tocchetti CG; Aversa M; Miranda M; D'Alessandro G; Cacace A; Ciampi Q; Chiariello M
    Circulation; 2003 Sep; 108(12):1455-60. PubMed ID: 12952838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction.
    Fassbach M; Schwartzkopff B
    Z Kardiol; 2005 May; 94(5):328-35. PubMed ID: 15868361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Yang C; Qiao S; Song Y; Liu Y; Tang Y; Deng L; Yuan J; Hu F; Yang W
    Cardiovasc Pathol; 2019; 43():107150. PubMed ID: 31639652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the utility of circulating biomarkers of collagen synthesis in hypertrophic cardiomyopathy.
    Ellims AH; Taylor AJ; Mariani JA; Ling LH; Iles LM; Maeder MT; Kaye DM
    Circ Heart Fail; 2014 Mar; 7(2):271-8. PubMed ID: 24481111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy.
    Münch J; Avanesov M; Bannas P; Säring D; Krämer E; Mearini G; Carrier L; Suling A; Lund G; Patten M
    J Card Fail; 2016 Oct; 22(10):845-50. PubMed ID: 27018569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles.
    Polyakova V; Loeffler I; Hein S; Miyagawa S; Piotrowska I; Dammer S; Risteli J; Schaper J; Kostin S
    Int J Cardiol; 2011 Aug; 151(1):18-33. PubMed ID: 20546954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
    Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
    Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation.
    Meel R; Nethononda R; Libhaber E; Dix-Peek T; Peters F; Essop M
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):150-154. PubMed ID: 29443354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of hypertrophic cardiomyopathy. Impact of growth factors on left ventricular anatomy.
    Migliore T; Parrella LS; Caputi A; Silvestri N; Romano R; Pace L; Imbriaco M; Losi MA; Betocchi S
    Minerva Cardioangiol; 2008 Feb; 56(1):13-20. PubMed ID: 18432164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure.
    Kaye DM; Khammy O; Mariani J; Maeder MT
    Eur J Heart Fail; 2013 Mar; 15(3):292-8. PubMed ID: 23143794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
    Aguiar P; Azevedo O; Pinto R; Marino J; Cardoso C; Sousa N; Cunha D; Hughes D; Ducla Soares JL
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
    Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P
    Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy.
    Schwartzkopff B; Fassbach M; Pelzer B; Brehm M; Strauer BE
    Eur J Heart Fail; 2002 Aug; 4(4):439-4. PubMed ID: 12167381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation.
    Kitaoka H; Kubo T; Okawa M; Takenaka N; Baba Y; Yamasaki N; Matsumura Y; Furuno T; Doi YL
    J Cardiol; 2011 Nov; 58(3):261-5. PubMed ID: 21890325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.
    Martos R; Baugh J; Ledwidge M; O'Loughlin C; Conlon C; Patle A; Donnelly SC; McDonald K
    Circulation; 2007 Feb; 115(7):888-95. PubMed ID: 17283265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure.
    López B; González A; Querejeta R; Larman M; Díez J
    J Am Coll Cardiol; 2006 Jul; 48(1):89-96. PubMed ID: 16814653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum biochemical markers of myocardial fibrosis and diastolic function at rest and with exercise in hypertrophic cardiomyopathy.
    Shim CY; Ha JW; Choi EY; Lee HJ; Moon SH; Kim JM; Rim SJ; Chung N
    Korean Circ J; 2009 Dec; 39(12):519-24. PubMed ID: 20049137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventricular volume indices.
    Murakami T; Kusachi S; Murakami M; Sano I; Uesugi T; Hirami R; Kajiyama A; Kondo J; Tsuji T
    Clin Chem; 1998 Dec; 44(12):2453-61. PubMed ID: 9836712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.